Antibodies News and Research

RSS

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.

6 Jul 2017

Biolegend chooses Chromatrap technology to power chromatin immunoprecipitation kits

Chromatrap® announces that BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research, has chosen their novel solid-state ChIP technology to power a new range of faster and more efficient chromatin immunoprecipitation kits.

From Chromatrap® - Porvair Sciences Ltd 30 Jun 2017

New therapeutic approach offers hope for individuals with debilitating bone cancer

An Australian-led research team has demonstrated a new therapeutic approach that can re-build and strengthen bone, offering hope for individuals with the debilitating bone cancer, multiple myeloma.

29 Jun 2017

Wyss Institute researchers develop new capture technology for cancer diagnostics

Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body's defense systems.

28 Jun 2017

New nanoallergen technology could help provide clear, accurate assessment of peanut allergies

Researchers have developed a novel platform to more accurately detect and identify the presence and severity of peanut allergies, without directly exposing patients to the allergen, according to a new study published in the journal Scientific Reports.

27 Jun 2017

New approaches to early detection of Parkinson's disease on the horizon

Detecting Parkinson's disease before non-reversible symptoms occur: New approaches to early detection are meant to ensure just that. They are based on detection of alpha-synuclein in the skin or intestines.

24 Jun 2017

Postnova integrate FFF and SEC systems for improved protein characterization and separation

Postnova Analytics reports on the extended data available through integrating its AF2000 MultiFlow Flow Field-Flow Fractionation (FFF) platform with its SC2000 modular multi-detector Size Exclusion chromatography (SEC) system.

From Postnova Analytics 23 Jun 2017

Researchers examine formation of functional amyloids by bacteria in real time

A team of scientists from the VIB lab of Han Remaut and the lab of Yves Dufrêne at UCL Louvain-La-Neuve collaborated on a study of functional amyloids -protein aggregates with the typical amyloid structure that do not lead to disease but rather serve a dedicated biological function.

21 Jun 2017

Study finds vaccine to lower cholesterol levels could also immunize against heart disease

In people with high cholesterol levels, the fat that is built up in the artery walls narrows the arteries causing a condition called atherosclerosis. A study published on 19th June in the European Heart Journal has found the likelihood of a vaccine that can immunize humans having atherosclerosis, subsequent to successful outcomes in a mouse model study. At present, phase I clinical trial has begun in patients to see the possibility of translating the study findings to humans.

20 Jun 2017

New TSRI study could have implications for development of flu vaccines, drug therapies

Scientists at The Scripps Research Institute have shown that for the virus that causes the flu, two wrongs can sometimes make a right.

15 Jun 2017

New tools can potentially play key role in early diagnosis of systemic sclerosis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis.

14 Jun 2017

Research may lead to more accurate and reliable diagnostic test for autoimmune disease

In autoimmune diseases, the immune system wrongly identifies its "enemy", and produces antibodies that attack the patient's own cells.

14 Jun 2017

Researchers identify key Lassa virus structure using powerful Argonne X-rays

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus.

13 Jun 2017

Altered virus could help more patients to become eligible for human gene therapy trials

For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment.

13 Jun 2017

Study finds that e-cigarettes are potentially as harmful as tobacco cigarettes in damaging DNA

A study by chemists at the University of Connecticut (UConn) offers new evidence that e-cigarettes loaded with a nicotine-based liquid are potentially as harmful as unfiltered cigarettes when it comes to causing DNA damage.

13 Jun 2017

Zika viral load not necessarily linked to pregnancy problems, fetal abnormalities

UCLA-led researchers have found that Zika viral load and the degree of Zika symptoms during pregnancy were not necessarily associated with problems during pregnancy or fetal abnormalities at birth.

13 Jun 2017

Common periodontal pathogen may delay conception in young women, study finds

According to a study carried out at the University of Helsinki, a common periodontal pathogen may delay conception in young women.

13 Jun 2017

UConn researchers find e-cigarettes to be equally harmful as tobacco cigarettes

A study by chemists at the University of Connecticut offers new evidence that electronic cigarettes or e-cigarettes are potentially as harmful as tobacco cigarettes.

12 Jun 2017

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

Scientists at Johns Hopkins have created a nanoparticle that carries two different antibodies capable of simultaneously switching off cancer cells' defensive properties while switching on a robust anticancer immune response in mice.

8 Jun 2017

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Building on insights from an HIV vaccine regimen in humans that had partial success during a phase 3 clinical trial in Thailand, a Duke-led research team used a more-is-better approach in monkeys that appeared to improve vaccine protection from an HIV-like virus.

8 Jun 2017

Antibodies News and Research

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

Biolegend chooses Chromatrap technology to power chromatin immunoprecipitation kits

New therapeutic approach offers hope for individuals with debilitating bone cancer

Wyss Institute researchers develop new capture technology for cancer diagnostics

New nanoallergen technology could help provide clear, accurate assessment of peanut allergies

New approaches to early detection of Parkinson's disease on the horizon

Postnova integrate FFF and SEC systems for improved protein characterization and separation

Researchers examine formation of functional amyloids by bacteria in real time

Study finds vaccine to lower cholesterol levels could also immunize against heart disease

New TSRI study could have implications for development of flu vaccines, drug therapies

New tools can potentially play key role in early diagnosis of systemic sclerosis

Research may lead to more accurate and reliable diagnostic test for autoimmune disease

Researchers identify key Lassa virus structure using powerful Argonne X-rays

Altered virus could help more patients to become eligible for human gene therapy trials

Study finds that e-cigarettes are potentially as harmful as tobacco cigarettes in damaging DNA

Zika viral load not necessarily linked to pregnancy problems, fetal abnormalities

Common periodontal pathogen may delay conception in young women, study finds

UConn researchers find e-cigarettes to be equally harmful as tobacco cigarettes

Scientists create 'immunoswitch' particles that slow cancer growth in test animals

More-is-better approach appears to improve vaccine protection from HIV-like virus in monkeys

Antibodies eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News